Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company, 17678-17681 [2018-08348]
Download as PDF
<![CDATA[
17678
Federal Register / Vol. 83, No. 78 / Monday, April 23, 2018 / Notices
that Nokia Solutions and Networks US
LLC no longer exists as of January 1,
2018. Based on this stipulation,
complainants agreed to withdraw the
complaint as to Nokia Solutions and
Networks B.V., Nokia Solutions and
Networks Oy, and Nokia Solutions and
Networks US LLC.
On March 19, 2018, the ALJ issued
the subject ID granting complainants’
motion. The ALJ found that good cause
exists to amend the complaint and there
is no evidence of any prejudice to the
parties in the investigation. The ALJ
found that no extraordinary
circumstances prevent the partial
termination of the investigation as to
Nokia Solutions and Networks B.V.,
Nokia Solutions and Networks Oy, and
Nokia Solutions and Networks US LLC.
None of the parties petitioned for review
of the subject ID.
The Commission has determined not
to review the ID.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in Part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
By order of the Commission.
Issued: April 17, 2018.
Lisa Barton,
Secretary to the Commission.
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Cayman
Chemical Company
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before June 22, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
DATES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on March
8, 2018, Cayman Chemical Company,
1180 East Ellsworth Road, Ann Arbor,
Michigan 48108 applied to be registered
as a bulk manufacturer of the following
basic classes of controlled substances:
SUPPLEMENTARY INFORMATION:
[FR Doc. 2018–08369 Filed 4–20–18; 8:45 am]
ACTION:
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
amozie on DSK30RV082PROD with NOTICES
Controlled substance
Drug code
3-Fluoro-N-methylcathinone (3–FMC) .....................................................................................................................
Cathinone .................................................................................................................................................................
Methcathinone .........................................................................................................................................................
4-Fluoro-N-methylcathinone (4–FMC) .....................................................................................................................
Pentedrone (a-methylaminovalerophenone) ...........................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ............................................................................................................
4-Methyl-N-ethylcathinone (4–MEC) .......................................................................................................................
Naphyrone ...............................................................................................................................................................
N-Ethylamphetamine ...............................................................................................................................................
N,N-Dimethylamphetamine ......................................................................................................................................
Fenethylline ..............................................................................................................................................................
Aminorex ..................................................................................................................................................................
4-Methylaminorex (cis isomer) ................................................................................................................................
Gamma Hydroxybutyric Acid ...................................................................................................................................
Methaqualone ..........................................................................................................................................................
Mecloqualone ...........................................................................................................................................................
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ..........................................................................................
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ........................................
ADB–FUBINACA (n-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .....
5-Flouro-UR–144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ........
AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .............
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ..............................................................................................................
MDMB–FUBINACA (Methyl 2-(1-4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ................
2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3- methylbutanoate ...................................................................
AB–PINACA (N-(1-amino-3-methyl- ........................................................................................................................
1-oxobutan-2-yl)-1-pentyl-1H-indazole- ...................................................................................................................
3-carboxamide) ........................................................................................................................................................
THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3- ............................................................................................................
yl](naphthalen-1-yl)methanone ................................................................................................................................
AB–CHMINACA (N-(1-amino-3-methyl-1- ...............................................................................................................
oxobutan-2-yl)-1-(cyclohexylmethyl)- .......................................................................................................................
1H-indazole-3-carboxamide .....................................................................................................................................
MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)
5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazola-3-carboxamido)-3-methylbutanoate) ......................................
5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5fluoropentyl)-1H-indazole-3-carboxamido)-3,3dimethylbutanoate)
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .........................
MDMB–CHMICA,
MMB–CHMINACA
(Methyl
2-(1-(cyclohenxylmethyl)-1H-indole-3-carboxamido)-3,3dimethylbutanote)- ................................................................................................................................................
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide .......................................................
VerDate Sep<11>2014
17:09 Apr 20, 2018
Jkt 244001
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
E:\FR\FM\23APN1.SGM
23APN1
Schedule
1233
1235
1237
1238
1246
1248
1249
1258
1475
1480
1503
1585
1590
2010
2565
2572
6250
7008
7010
7011
7012
7019
7020
7021
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
7023
I
7024
I
7031
7032
7033
7034
7035
I
I
I
I
I
7042
7048
I
I
17679
Federal Register / Vol. 83, No. 78 / Monday, April 23, 2018 / Notices
amozie on DSK30RV082PROD with NOTICES
Controlled substance
Drug code
5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5fluoropentyl)-1H-indazole-3-carboxamide) ............................
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ..........................................................................................
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ............................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ......................................................................
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) .............................................................................................
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone .........................................................
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ...............................................................................................................
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ..................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ...............................................................................................
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ..............................................................................................
PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) .........................................................................................
5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ....................................................................
Alpha-ethyltryptamine ..............................................................................................................................................
Ibogaine ...................................................................................................................................................................
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) .........................................................
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ...................................
Lysergic acid diethylamide ......................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) ......................................................................................
Marihuana ................................................................................................................................................................
Tetrahydrocannabinols ............................................................................................................................................
Mescaline .................................................................................................................................................................
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2 ) ..................................................................................
3,4,5-Trimethoxyamphetamine ................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine ......................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ..................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine ......................................................................................................................
2,5-Dimethoxyamphetamine ....................................................................................................................................
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ..............................................................................................
2,5-Dimethoxy-4-ethylamphetamine ........................................................................................................................
3,4-Methylenedioxyamphetamine ............................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine ..........................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ..........................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine ...............................................................................................................
3,4-Methylenedioxymethamphetamine ....................................................................................................................
4-Methoxyamphetamine ..........................................................................................................................................
5-Methoxy-N-N-dimethyltryptamine .........................................................................................................................
Alpha-methyltryptamine ...........................................................................................................................................
Diethyltryptamine .....................................................................................................................................................
Dimethyltryptamine ..................................................................................................................................................
Psilocybin .................................................................................................................................................................
Psilocyn ....................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine ......................................................................................................................
N-Ethyl-1-phenylcyclohexylamine ............................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine ............................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine .......................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine ......................................................................................................................
N-Benzylpiperazine ..................................................................................................................................................
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D) ..........................................................................................
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C–E ) ............................................................................................
2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) .........................................................................................................
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C–I) ................................................................................................
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C–C) ..........................................................................................
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C–N) ............................................................................................
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C–P) .....................................................................................
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C–T–4 ) ...........................................................................
MDPV (3,4-Methylenedioxypyrovalerone) ...............................................................................................................
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B–NBOMe) ............................................
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) .........................................................................................
ethanamine (25C–NBOMe) .....................................................................................................................................
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I–NBOMe) .................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ..............................................................................................
Butylone ...................................................................................................................................................................
Pentylone .................................................................................................................................................................
alpha-pyrrolidinopentiophenone (a-PVP) ................................................................................................................
alpha-pyrrolidinobutiophenone (a-PBP) ..................................................................................................................
AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ...........................................................................................
Acetyldihydrocodeine ...............................................................................................................................................
Benzylmorphine .......................................................................................................................................................
Codeine-N-oxide ......................................................................................................................................................
Desomorphine ..........................................................................................................................................................
Etorphine (except HCl) ............................................................................................................................................
Codeine methylbromide ...........................................................................................................................................
Dihydromorphine ......................................................................................................................................................
Heroin ......................................................................................................................................................................
VerDate Sep<11>2014
17:09 Apr 20, 2018
Jkt 244001
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
E:\FR\FM\23APN1.SGM
23APN1
Schedule
7049
7081
7104
7118
7122
7144
7173
7200
7201
7203
7222
7225
7249
7260
7297
7298
7315
7348
7360
7370
7381
7385
7390
7391
7392
7395
7396
7398
7399
7400
7401
7402
7404
7405
7411
7431
7432
7434
7435
7437
7438
7439
7455
7458
7470
7473
7493
7508
7509
7517
7518
7519
7521
7524
7532
7535
7536
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
7537
7538
7540
7541
7542
7545
7546
7694
9051
9052
9053
9055
9056
9070
9145
9200
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
17680
Federal Register / Vol. 83, No. 78 / Monday, April 23, 2018 / Notices
amozie on DSK30RV082PROD with NOTICES
Controlled substance
Drug code
Morphine-N-oxide ....................................................................................................................................................
Normorphine ............................................................................................................................................................
U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ......................................................
MT–45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) ...........................................................................................
Tilidine ......................................................................................................................................................................
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) .........................................................................
Para-Fluorofentanyl .................................................................................................................................................
3-Methylfentanyl .......................................................................................................................................................
Alpha-methylfentanyl ...............................................................................................................................................
Acetyl-alpha-methylfentanyl .....................................................................................................................................
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ...............................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) .......................................................................
Butyryl Fentanyl .......................................................................................................................................................
Para-fluorobutyryl fentanyl .......................................................................................................................................
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1phenethylpiperidin-4-yl)isobutyramide) ..................................
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide .................................................................................
Para-chloroisobutyryl fentanyl .................................................................................................................................
Isobutyryl fentanyl ....................................................................................................................................................
Beta-hydroxyfentanyl ...............................................................................................................................................
Beta-hydroxy-3-methylfentanyl ................................................................................................................................
Alpha-methylthiofentanyl ..........................................................................................................................................
3-Methylthiofentanyl .................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) .....................................................
Thiofentanyl .............................................................................................................................................................
Beta-hydroxythiofentanyl .........................................................................................................................................
Para-methoxybutyryl fentanyl ..................................................................................................................................
Ocfentanil .................................................................................................................................................................
Valeryl fentanyl ........................................................................................................................................................
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide ..................................................................
Cyclopropyl Fentanyl ...............................................................................................................................................
Cyclopentyl fentanyl .................................................................................................................................................
Fentanyl related-compounds as defined in 21 CFR 1308.11(h) .............................................................................
Amphetamine ...........................................................................................................................................................
Methamphetamine ...................................................................................................................................................
Lisdexamfetamine ....................................................................................................................................................
Phenmetrazine .........................................................................................................................................................
Methylphenidate .......................................................................................................................................................
Amobarbital ..............................................................................................................................................................
Pentobarbital ............................................................................................................................................................
Secobarbital .............................................................................................................................................................
Phencyclidine ...........................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) .............................................................................................................
Phenylacetone .........................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ........................................................................................................................
Cocaine ....................................................................................................................................................................
Codeine ....................................................................................................................................................................
Etorphine HCl ..........................................................................................................................................................
Dihydrocodeine ........................................................................................................................................................
Oxycodone ...............................................................................................................................................................
Hydromorphone .......................................................................................................................................................
Ecgonine ..................................................................................................................................................................
Ethylmorphine ..........................................................................................................................................................
Hydrocodone ............................................................................................................................................................
Levomethorphan ......................................................................................................................................................
Levorphanol .............................................................................................................................................................
Isomethadone ..........................................................................................................................................................
Meperidine ...............................................................................................................................................................
Meperidine intermediate-B .......................................................................................................................................
Methadone ...............................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ......................................................................................................
Morphine ..................................................................................................................................................................
Thebaine ..................................................................................................................................................................
Oxymorphone ..........................................................................................................................................................
Thiafentanil ..............................................................................................................................................................
Alfentanil ..................................................................................................................................................................
Remifentanil .............................................................................................................................................................
Sufentanil .................................................................................................................................................................
Carfentanil ................................................................................................................................................................
Tapentadol ...............................................................................................................................................................
Fentanyl ...................................................................................................................................................................
VerDate Sep<11>2014
17:09 Apr 20, 2018
Jkt 244001
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
E:\FR\FM\23APN1.SGM
23APN1
9307
9313
9547
9560
9750
9811
9812
9813
9814
9815
9816
9821
9822
9823
9824
9825
9826
9827
9830
9831
9832
9833
9834
9835
9836
9837
9838
9840
9843
9845
9847
9850
1100
1105
1205
1631
1724
2125
2270
2315
7471
8333
8501
8603
9041
9050
9059
9120
9143
9150
9180
9190
9193
9210
9220
9226
9230
9233
9250
9273
9300
9333
9652
9729
9737
9739
9740
9743
9780
9801
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Federal Register / Vol. 83, No. 78 / Monday, April 23, 2018 / Notices
The company plans to manufacture
bulk controlled substances for use in
product development of analytical
reference standards for distribution to
its customers.
The company will manufacture
marihuana (7360) and
tetrahydrocannabinols (7370) for use by
their researchers under the above-listed
controlled substances as Active
Pharmaceutical Ingredient (API) for
clinical trials.
In reference to drug code (7370) the
company plans to bulk manufacture a
synthetic tetrahydrocannabinol. No
other activities for this drug code are
authorized for this registration.
proof of delivery from another delivery
service such as UPS or Federal Express
on or before the deadline for comments.
FOR FURTHER INFORMATION CONTACT:
Barbara Barron, Office of Standards,
Regulations, and Variances at 202–693–
9447 (Voice), barron.barbara@dol.gov
(email), or 202–693–9441 (Facsimile).
[These are not toll-free numbers.]
SUPPLEMENTARY INFORMATION: Section
101(c) of the Federal Mine Safety and
Health Act of 1977 and Title 30 of the
Code of Federal Regulations Part 44
govern the application, processing, and
disposition of petitions for modification.
Dated: April 13, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
Section 101(c) of the Federal Mine
Safety and Health Act of 1977 (Mine
Act) allows the mine operator or
representative of miners to file a
petition to modify the application of any
mandatory safety standard to a coal or
other mine if the Secretary of Labor
(Secretary) determines that:
1. An alternative method of achieving
the result of such standard exists which
will at all times guarantee no less than
the same measure of protection afforded
the miners of such mine by such
standard; or
2. That the application of such
standard to such mine will result in a
diminution of safety to the miners in
such mine.
In addition, the regulations at 30 CFR
44.10 and 44.11 establish the
requirements and procedures for filing
petitions for modification.
[FR Doc. 2018–08348 Filed 4–20–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Mine Safety and Health Administration
Petitions for Modification of
Application of Existing Mandatory
Safety Standards
Mine Safety and Health
Administration, Labor.
ACTION: Notice.
AGENCY:
This notice is a summary of
petitions for modification submitted to
the Mine Safety and Health
Administration (MSHA) by the parties
listed below.
DATES: All comments on the petitions
must be received by MSHA’s Office of
Standards, Regulations, and Variances
on or before May 23, 2018.
ADDRESSES: You may submit your
comments, identified by ‘‘docket
number’’ on the subject line, by any of
the following methods:
1. Electronic Mail: zzMSHAcomments@dol.gov. Include docket
number of the petition in the subject
line of the message.
2. Facsimile: 202–693–9441.
3. Regular Mail or Hand Delivery:
MSHA, Office of Standards,
Regulations, and Variances, 201 12th
Street South, Suite 4E401, Arlington,
Virginia 22202–5452, Attention: Sheila
McConnell, Director, Office of
Standards, Regulations, and Variances.
Persons delivering documents are
required to check in at the receptionist’s
desk in Suite 4E401. Individuals may
inspect copies of the petition and
comments during normal business
hours at the address listed above.
MSHA will consider only comments
postmarked by the U.S. Postal Service or
amozie on DSK30RV082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:09 Apr 20, 2018
Jkt 244001
I. Background
II. Petitions for Modification
Docket Number: M–2018–006–C.
Petitioner: Wolf Run Mining LLC,
21550 Barbour County Highway,
Philippi, West Virginia 26416.
Mine: Sentinel Mine, MSHA I.D. No.
46–04168, located in Barbour County,
West Virginia.
Regulation Affected: 30 CFR 75.500(d)
(Permissible electric equipment).
Modification Request: The petitioner
requests a modification of the existing
standard to permit an alternative
method of compliance to allow the use
of nonpermissible electronic lowvoltage or battery-powered
nonpermissible electronic hand-held
drill equipment in or inby the last open
crosscut.
The petitioner states that:
(1) Nonpermissible electronic lowvoltage or battery-powered
nonpermissible electronic equipment
will be limited to hand-held drill
equipment.
(2) All other hand-held drill
equipment used in or inby the last open
crosscut will be permissible.
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
17681
(3) Other hand-held drill equipment
may be used if approved in advance by
the MSHA District Manager.
(4) All nonpermissible low-voltage or
battery-powered nonpermissible handheld equipment to be used in or inby
the last open crosscut will be examined
prior to use by a certified person to
ensure the equipment is being
maintained in a safe operating
condition.
(5) The results of the examinations
will be recorded and retained for one
year and made available to MSHA on
request.
(6) A qualified person, as defined in
30 CFR 75.151, will continuously
monitor for methane immediately before
and during the use of nonpermissible
hand-held drill equipment in or inby
the last open crosscut.
(7) Nonpermissible hand-held drill
equipment will not be used if methane
is detected in concentrations at or above
1.0 percent. When methane is detected
at such level while the nonpermissible
hand-held drill equipment is being
used, the equipment will be deenergized
immediately and withdrawn outby the
last open crosscut.
(8) All hand-held methane detectors
will be MSHA-approved and
maintained in permissible and proper
operating condition as defined in 30
CFR 75.320.
(9) Coal production will cease in the
entry or crosscut where the
nonpermissible hand-held drill
equipment is in use. Accumulations of
coal and combustible materials
referenced in 30 CFR 75.400 will be
removed before drilling begins to
provide additional safety to miners.
(10) Nonpermissible electronic handheld drill equipment will not be used
when float coal dust is in suspension.
(11) All hand-held drill equipment
will be used in accordance with the
manufacturer’s recommended safe use
procedures.
(12) Qualified personnel who use
nonpermissible hand-held drill
equipment will be properly trained to
recognize the hazards and limitations
associated with use of such equipment
in areas where methane could be
present.
(13) The nonpermissible electronic
hand-held drill equipment will not be
put into service until MSHA has
initially inspected the equipment and
determined that it is in compliance with
all of the above terms and conditions.
(14) Cables supplying power to lowvoltage hand-held drill equipment will
only be used when permissible handheld drill equipment is not available.
Within 60 days after the Proposed
Decision and Order (PDO) becomes
E:\FR\FM\23APN1.SGM
23APN1
]]>Agencies
[Federal Register Volume 83, Number 78 (Monday, April 23, 2018)]
[Notices]
[Pages 17678-17681]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-08348]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Cayman
Chemical Company
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before June 22, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on March
8, 2018, Cayman Chemical Company, 1180 East Ellsworth Road, Ann Arbor,
Michigan 48108 applied to be registered as a bulk manufacturer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC)...... 1233 I
Cathinone............................... 1235 I
Methcathinone........................... 1237 I
4-Fluoro-N-methylcathinone (4-FMC)...... 1238 I
Pentedrone ([alpha]- 1246 I
methylaminovalerophenone)..............
Mephedrone (4-Methyl-N-methylcathinone). 1248 I
4-Methyl-N-ethylcathinone (4-MEC)....... 1249 I
Naphyrone............................... 1258 I
N-Ethylamphetamine...................... 1475 I
N,N-Dimethylamphetamine................. 1480 I
Fenethylline............................ 1503 I
Aminorex................................ 1585 I
4-Methylaminorex (cis isomer)........... 1590 I
Gamma Hydroxybutyric Acid............... 2010 I
Methaqualone............................ 2565 I
Mecloqualone............................ 2572 I
JWH-250 (1-Pentyl-3-(2- 6250 I
methoxyphenylacetyl) indole)...........
SR-18 (Also known as RCS-8) (1- 7008 I
Cyclohexylethyl-3-(2-
methoxyphenylacetyl) indole)...........
ADB-FUBINACA (n-(1-amino-3,3-dimethyl-1- 7010 I
oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
indazole-3-carboxamide)................
5-Flouro-UR-144 and XLR11 [1-(5-Fluoro- 7011 I
pentyl)1H-indol-3-yl](2,2,3,3-
tetramethylcyclopropyl)methanone.......
AB-FUBINACA (N-(1-amino-3-methyl-1- 7012 I
oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
indazole-3-carboxamide)................
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole). 7019 I
MDMB-FUBINACA (Methyl 2-(1-4- 7020 I
fluorobenzyl)-1H-indazole-3-
carboxamido)-3,3-dimethylbutanoate)....
2-(1-(4-fluorobenzyl)-1Hindazole-3- 7021 I
carboxamido)-3- methylbutanoate........
AB-PINACA (N-(1-amino-3-methyl-......... 7023 I
1-oxobutan-2-yl)-1-pentyl-1H-indazole-..
3-carboxamide)..........................
THJ-2201 [1-(5-fluoropentyl)-1H-indazol- 7024 I
3-.....................................
yl](naphthalen-1-yl)methanone...........
AB-CHMINACA (N-(1-amino-3-methyl-1-..... 7031 I
oxobutan-2-yl)-1-(cyclohexylmethyl)-....
1H-indazole-3-carboxamide...............
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1- 7032 I
oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
indazole-3-carboxamide)................
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H- 7033 I
indazola-3-carboxamido)-3-
methylbutanoate).......................
5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1- 7034 I
(5fluoropentyl)-1H-indazole-3-
carboxamido)-3,3dimethylbutanoate).....
ADB-PINACA (N-(1-amino-3,3-dimethyl-1- 7035 I
oxobutan-2-yl)-1-pentyl-1H-indazole-3-
carboxamide)...........................
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1- 7042 I
(cyclohenxylmethyl)-1H-indole-3-
carboxamido)-3,3-dimethylbutanote)-....
APINACA and AKB48 N-(1-Adamantyl)-1- 7048 I
pentyl-1H-indazole-3-carboxamide.......
[[Page 17679]]
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)- 7049 I
1-(5fluoropentyl)-1H-indazole-3-
carboxamide)...........................
JWH-081 (1-Pentyl-3-(1-(4- 7081 I
methoxynaphthoyl) indole)..............
SR-19 (Also known as RCS-4) (1-Pentyl-3- 7104 I
[(4-methoxy)-benzoyl] indole...........
JWH-018 (also known as AM678) (1-Pentyl- 7118 I
3-(1-naphthoyl)indole).................
JWH-122 (1-Pentyl-3-(4-methyl-1- 7122 I
naphthoyl) indole).....................
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I
tetramethylcyclopropyl)methanone.......
JWH-073 (1-Butyl-3-(1-naphthoyl)indole). 7173 I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- 7200 I
naphthoyl)indole)......................
AM2201 (1-(5-Fluoropentyl)-3-(1- 7201 I
naphthoyl) indole).....................
JWH-203 (1-Pentyl-3-(2- 7203 I
chlorophenylacetyl) indole)............
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole- 7222 I
3-carboxylate).........................
5F-PB-22 (Quinolin-8-yl 1-(5- 7225 I
fluoropentyl)-1H-indole-3-carboxylate).
Alpha-ethyltryptamine................... 7249 I
Ibogaine................................ 7260 I
CP-47,497 (5-(1,1-Dimethylheptyl)-2- 7297 I
[(1R,3S)-3-hydroxycyclohexyl-phenol)...
CP-47,497 C8 Homologue (5-(1,1- 7298 I
Dimethyloctyl)-2-[(1R,3S)3-
hydroxycyclohexyl-phenol)..............
Lysergic acid diethylamide.............. 7315 I
2,5-Dimethoxy-4-(n)- 7348 I
propylthiophenethylamine (2C-T-7)......
Marihuana............................... 7360 I
Tetrahydrocannabinols................... 7370 I
Mescaline............................... 7381 I
2-(4-Ethylthio-2,5-dimethoxyphenyl) 7385 I
ethanamine (2C-T-2 )...................
3,4,5-Trimethoxyamphetamine............. 7390 I
4-Bromo-2,5-dimethoxyamphetamine........ 7391 I
4-Bromo-2,5-dimethoxyphenethylamine..... 7392 I
4-Methyl-2,5-dimethoxyamphetamine....... 7395 I
2,5-Dimethoxyamphetamine................ 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I
naphthoyl) indole).....................
2,5-Dimethoxy-4-ethylamphetamine........ 7399 I
3,4-Methylenedioxyamphetamine........... 7400 I
5-Methoxy-3,4-methylenedioxyamphetamine. 7401 I
N-Hydroxy-3,4-methylenedioxyamphetamine. 7402 I
3,4-Methylenedioxy-N-ethylamphetamine... 7404 I
3,4-Methylenedioxymethamphetamine....... 7405 I
4-Methoxyamphetamine.................... 7411 I
5-Methoxy-N-N-dimethyltryptamine........ 7431 I
Alpha-methyltryptamine.................. 7432 I
Diethyltryptamine....................... 7434 I
Dimethyltryptamine...................... 7435 I
Psilocybin.............................. 7437 I
Psilocyn................................ 7438 I
5-Methoxy-N,N-diisopropyltryptamine..... 7439 I
N-Ethyl-1-phenylcyclohexylamine......... 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine....... 7458 I
1-[1-(2-Thienyl)cyclohexyl]piperidine... 7470 I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine.. 7473 I
N-Benzylpiperazine...................... 7493 I
2-(2,5-Dimethoxy-4-methylphenyl) 7508 I
ethanamine (2C-D)......................
2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I
ethanamine (2C-E ).....................
2-(2,5-Dimethoxyphenyl) ethanamine (2C- 7517 I
H).....................................
2-(4-iodo-2,5-dimethoxyphenyl) 7518 I
ethanamine (2C-I)......................
2-(4-Chloro-2,5-dimethoxyphenyl) 7519 I
ethanamine (2C-C)......................
2-(2,5-Dimethoxy-4-nitro-phenyl) 7521 I
ethanamine (2C-N)......................
2-(2,5-Dimethoxy-4-(n)-propylphenyl) 7524 I
ethanamine (2C-P)......................
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) 7532 I
ethanamine (2C-T-4 )...................
MDPV (3,4-Methylenedioxypyrovalerone)... 7535 I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2- 7536 I
methoxybenzyl) ethanamine (25B-NBOMe)..
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2- 7537 I
methoxybenzyl).........................
ethanamine (25C-NBOMe)..................
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- 7538 I
methoxybenzyl) ethanamine (25I-NBOMe)..
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).......................
Butylone................................ 7541 I
Pentylone............................... 7542 I
alpha-pyrrolidinopentiophenone ([alpha]- 7545 I
PVP)...................................
alpha-pyrrolidinobutiophenone ([alpha]- 7546 I
PBP)...................................
AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I
iodobenzoyl) indole)...................
Acetyldihydrocodeine.................... 9051 I
Benzylmorphine.......................... 9052 I
Codeine-N-oxide......................... 9053 I
Desomorphine............................ 9055 I
Etorphine (except HCl).................. 9056 I
Codeine methylbromide................... 9070 I
Dihydromorphine......................... 9145 I
Heroin.................................. 9200 I
[[Page 17680]]
Morphine-N-oxide........................ 9307 I
Normorphine............................. 9313 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-
methylbenzamide).......................
MT-45 (1-cyclohexyl-4-(1,2- 9560 I
diphenylethyl)piperazine)).............
Tilidine................................ 9750 I
Acryl fentanyl (N-(1-phenethylpiperidin- 9811 I
4-yl)-N-phenylacrylamide)..............
Para-Fluorofentanyl..................... 9812 I
3-Methylfentanyl........................ 9813 I
Alpha-methylfentanyl.................... 9814 I
Acetyl-alpha-methylfentanyl............. 9815 I
N-(2-fluorophenyl)-N-(1- 9816 I
phenethylpiperidin-4-yl)propionamide...
Acetyl Fentanyl (N-(1-phenethylpiperidin- 9821 I
4-yl)-N-phenylacetamide)...............
Butyryl Fentanyl........................ 9822 I
Para-fluorobutyryl fentanyl............. 9823 I
4-Fluoroisobutyryl fentanyl (N-(4- 9824 I
fluorophenyl)-N-(1phenethylpiperidin-4-
yl)isobutyramide)......................
2-methoxy-N-(1-phenethylpiperidin-4-yl)- 9825 I
N-phenylacetamide......................
Para-chloroisobutyryl fentanyl.......... 9826 I
Isobutyryl fentanyl..................... 9827 I
Beta-hydroxyfentanyl.................... 9830 I
Beta-hydroxy-3-methylfentanyl........... 9831 I
Alpha-methylthiofentanyl................ 9832 I
3-Methylthiofentanyl.................... 9833 I
Furanyl fentanyl (N-(1- 9834 I
phenethylpiperidin-4-yl)-N-phenylfuran-
2-carboxamide).........................
Thiofentanyl............................ 9835 I
Beta-hydroxythiofentanyl................ 9836 I
Para-methoxybutyryl fentanyl............ 9837 I
Ocfentanil.............................. 9838 I
Valeryl fentanyl........................ 9840 I
N-(1-phenethylpiperidin-4-yl)-N- 9843 I
phenyltetrahydrofuran-2-carboxamide....
Cyclopropyl Fentanyl.................... 9845 I
Cyclopentyl fentanyl.................... 9847 I
Fentanyl related-compounds as defined in 9850 I
21 CFR 1308.11(h)......................
Amphetamine............................. 1100 II
Methamphetamine......................... 1105 II
Lisdexamfetamine........................ 1205 II
Phenmetrazine........................... 1631 II
Methylphenidate......................... 1724 II
Amobarbital............................. 2125 II
Pentobarbital........................... 2270 II
Secobarbital............................ 2315 II
Phencyclidine........................... 7471 II
4-Anilino-N-phenethyl-4-piperidine 8333 II
(ANPP).................................
Phenylacetone........................... 8501 II
1-Piperidinocyclohexanecarbonitrile..... 8603 II
Cocaine................................. 9041 II
Codeine................................. 9050 II
Etorphine HCl........................... 9059 II
Dihydrocodeine.......................... 9120 II
Oxycodone............................... 9143 II
Hydromorphone........................... 9150 II
Ecgonine................................ 9180 II
Ethylmorphine........................... 9190 II
Hydrocodone............................. 9193 II
Levomethorphan.......................... 9210 II
Levorphanol............................. 9220 II
Isomethadone............................ 9226 II
Meperidine.............................. 9230 II
Meperidine intermediate-B............... 9233 II
Methadone............................... 9250 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).................................
Morphine................................ 9300 II
Thebaine................................ 9333 II
Oxymorphone............................. 9652 II
Thiafentanil............................ 9729 II
Alfentanil.............................. 9737 II
Remifentanil............................ 9739 II
Sufentanil.............................. 9740 II
Carfentanil............................. 9743 II
Tapentadol.............................. 9780 II
Fentanyl................................ 9801 II
------------------------------------------------------------------------
[[Page 17681]]
The company plans to manufacture bulk controlled substances for use
in product development of analytical reference standards for
distribution to its customers.
The company will manufacture marihuana (7360) and
tetrahydrocannabinols (7370) for use by their researchers under the
above-listed controlled substances as Active Pharmaceutical Ingredient
(API) for clinical trials.
In reference to drug code (7370) the company plans to bulk
manufacture a synthetic tetrahydrocannabinol. No other activities for
this drug code are authorized for this registration.
Dated: April 13, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018-08348 Filed 4-20-18; 8:45 am]
BILLING CODE 4410-09-P
